PGNY vs HCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PGNY

61.0
AI Score
VS
PGNY Wins

HCAT

47.4
AI Score

Investment Advisor Scores

PGNY

61score
Recommendation
STRONG BUY

HCAT

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PGNY HCAT Winner
Forward P/E 12.4378 7.764 HCAT
PEG Ratio 0 0 Tie
Revenue Growth 5.3% -12.7% PGNY
Earnings Growth 78.9% 0.0% PGNY
Tradestie Score 61.0/100 47.4/100 PGNY
Profit Margin 6.0% -90.6% PGNY
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD PGNY

Relative Price Performance (Last 90 Days)

PGNY 1M: +7.6% · 3M: +6.6% HCAT 1M: -5.0% · 3M: +3.7%

Current Technical Phase

PGNY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.8 · Price: $27.35

HCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $1.70

Fundamentals Snapshot

Metric PGNY HCAT
Market Cap
Forward P/E 11.8 215.2
Trailing P/E 29.4
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% -0.1%
EPS 0.92 -3.68
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PGNY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.